Latest publications
-
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition.
Ayyadevara VSSA. et al, (2025), Leukemia
-
BCL11B-related disease: a single phenotypic entity?
Vedovato-dos-Santos JH. et al, (2025), European Journal of Human Genetics
-
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study.
Zeidner JF. et al, (2025), Blood
-
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline.
Yang X. et al, (2025), Adv Healthc Mater
-
Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers.
Goncalves T. et al, (2025), Nucleic Acids Res, 53
Upcoming Seminars
-
Thursday, 17 April 2025, 12pm to 1pm
Speakers: Professor Eirini Papapetrou
-
Wednesday, 30 April 2025, 1.30pm to 2.30pm
Speakers: Dr Andreas Wack
-
Thursday, 01 May 2025, 12pm to 1pm
Speakers: Professor Adrian Liston
-
Thursday, 08 May 2025, 12pm to 1pm
Speakers: Dr Raheleh Rahbari
-
Friday, 09 May 2025, 9.15am to 10.15am
Speakers: Dr Abhinandan Devaprasad